ABBOTINDIA Stock Overview
Operates as a pharmaceutical company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Abbott India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹27,378.30 |
| 52 Week High | ₹30,521.00 |
| 52 Week Low | ₹22,000.00 |
| Beta | 0.013 |
| 11 Month Change | -3.84% |
| 3 Month Change | -9.33% |
| 1 Year Change | 15.01% |
| 33 Year Change | 44.06% |
| 5 Year Change | 114.35% |
| Change since IPO | 3,469.53% |
Recent News & Updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Recent updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Shareholder Returns
| ABBOTINDIA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.0% | 0.8% | 2.9% |
| 1Y | 15.0% | 42.1% | 28.9% |
Return vs Industry: ABBOTINDIA underperformed the Indian Pharmaceuticals industry which returned 42.1% over the past year.
Return vs Market: ABBOTINDIA underperformed the Indian Market which returned 28.9% over the past year.
Price Volatility
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: ABBOTINDIA has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ABBOTINDIA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.
Abbott India Limited Fundamentals Summary
| ABBOTINDIA fundamental statistics | |
|---|---|
| Market cap | ₹584.47b |
| Earnings (TTM) | ₹12.85b |
| Revenue (TTM) | ₹60.66b |
45.3x
P/E Ratio9.6x
P/S RatioIs ABBOTINDIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABBOTINDIA income statement (TTM) | |
|---|---|
| Revenue | ₹60.66b |
| Cost of Revenue | ₹33.43b |
| Gross Profit | ₹27.23b |
| Other Expenses | ₹14.39b |
| Earnings | ₹12.85b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 604.57 |
| Gross Margin | 44.89% |
| Net Profit Margin | 21.18% |
| Debt/Equity Ratio | 0% |
How did ABBOTINDIA perform over the long term?
See historical performance and comparison